{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:47:07Z","timestamp":1791924427500,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"DOI":"10.1007\/s00726-026-03535-z","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:12:58Z","timestamp":1784297578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Succinylation related gene signature enables risk stratification and prognostic modeling in breast cancer patients"],"prefix":"10.1007","volume":"58","author":[{"given":"Zhifeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"9","key":"3535_CR1","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41388-020-01637-w","volume":"40","author":"YLN Abril","year":"2021","unstructured":"Abril YLN, Fernandez IR, Hong JY, Chiang YL, Kutateladze DA, Zhao Q, Yang M, Hu J, Sadhukhan S, Li B, He B, Remick B, Bai JJ, Mullmann J, Wang F, Maymi V, Dhawan R, Auwerx J, Southard T, Cerione RA, Lin H, Weiss RS (2021) Pharmacological and genetic perturbation establish sirt5 as a promising target in breast cancer. Oncogene 40(9):1644\u20131658","journal-title":"Oncogene"},{"issue":"10","key":"3535_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1607","volume":"6","author":"T Akter","year":"2023","unstructured":"Akter T, Aziz MA, Islam MS, Sarwar MS (2023) Association of mmp1 gene polymorphisms with breast cancer risk: a narrative review. Health Sci Rep 6(10):e1607","journal-title":"Health Sci Rep"},{"key":"3535_CR3","doi-asserted-by":"crossref","unstructured":"Avalos-Navarro G, Bautista-Herrera LA, Garibaldi-Rios AF, Ramirez-Patino R, Gutierrez-Garcia M, Briseno-Alvarez P, Jave-Suarez LF, Reyes-Uribe E, Gallegos-Arreola MP (2024) Serum alpha1-at levels and serpina1 molecular analysis in breast cancer: An experimental and computational study. Diseases 13 (1)","DOI":"10.3390\/diseases13010001"},{"key":"3535_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106535","volume":"84","author":"K Barzaman","year":"2020","unstructured":"Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, Safari E, Farahmand L (2020) Breast cancer: biology, biomarkers, and treatments. Int Immunopharmacol 84:10653","journal-title":"Int Immunopharmacol"},{"issue":"23","key":"3535_CR5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217332120","volume":"120","author":"AC Boese","year":"2023","unstructured":"Boese AC, Kang J, Hwang JS, Kim J, Eun K, Malin CM, Magliocca KR, Pan C, Jin L, Kang S (2023) Succinyl-CoA ligase ADP-forming subunit beta promotes stress granule assembly to regulate redox and drive cancer metastasis. Proc Natl Acad Sci U S A 120(23):e2217332120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3535_CR6","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"3535_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00997","volume":"10","author":"B Chatterjee","year":"2019","unstructured":"Chatterjee B, Roy P, Sarkar UA, Zhao M, Ratra Y, Singh A, Chawla M, De S, Gomes J, Sen R, Basak S (2019) Immune differentiation regulator p100 tunes NF-\u03baB responses to TNF. Front Immunol 10:997","journal-title":"Front Immunol"},{"key":"3535_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.984564","volume":"9","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wang W, Fang L, Zhang Z, Deng S (2022) Identification of ptk2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses. Front Mol Biosci 9:984564","journal-title":"Front Mol Biosci"},{"issue":"1","key":"3535_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07615-y","volume":"16","author":"L Chen","year":"2025","unstructured":"Chen L, Cen Y, Qian K, Yang W, Zhou W, Yang Y (2025) Mmp1-induced NF-\u03baB activation promotes epithelial-mesenchymal transition and Sacituzumab Govitecan resistance in hormone receptor-positive breast cancer. Cell Death Dis 16(1):346","journal-title":"Cell Death Dis"},{"issue":"1","key":"3535_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01058-x","volume":"28","author":"S Cui","year":"2023","unstructured":"Cui S, Feng J, Tang X, Lou S, Guo W, Xiao X, Li S, Chen X, Huan Y, Zhou Y, Xiao L (2023) The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients. Eur J Med Res 28(1):90","journal-title":"Eur J Med Res"},{"key":"3535_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1495221","volume":"15","author":"X Duan","year":"2024","unstructured":"Duan X, Xing Z, Qiao L, Qin S, Zhao X, Gong Y, Li X (2024) The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications. Front Immunol 15:1495221","journal-title":"Front Immunol"},{"issue":"4","key":"3535_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108368","volume":"301","author":"TC Fan","year":"2025","unstructured":"Fan TC, Yeo HL, Hung TH, Chang NC, Tang YH, Yu J, Chen SH, Yu AL (2025) St3gal1 regulates cancer cell migration through crosstalk between EGFR and neuropilin-1 signaling. J Biol Chem 301(4):108368","journal-title":"J Biol Chem"},{"issue":"1","key":"3535_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02582-4","volume":"24","author":"A Feng","year":"2023","unstructured":"Feng A, Caro YM, Gardner C, Grischo G, Liang Y, Wickremasinghe PD, Polmann M, Kala M, Marlowe T, Black SM, Knox KS, Wang T (2023) Ptk2-associated gene signature could predict the prognosis of IPF. Respir Res 24(1):304","journal-title":"Respir Res"},{"key":"3535_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1336057","volume":"11","author":"X Hou","year":"2024","unstructured":"Hou X, Chen Y, Li X, Gu X, Dong W, Shi J, Ji S (2024) Protein succinylation: regulating metabolism and beyond. Front Nutr 11:1336057","journal-title":"Front Nutr"},{"issue":"5","key":"3535_CR15","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.7150\/ijbs.75340","volume":"19","author":"Q Huo","year":"2023","unstructured":"Huo Q, Chen S, Zhuang J, Quan C, Wang Y, Xie N (2023) Sirt7 downregulation promotes breast cancer metastasis via LAP2alpha-induced chromosomal instability. Int J Biol Sci 19(5):1528\u20131542","journal-title":"Int J Biol Sci"},{"issue":"6","key":"3535_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/bioinformatics\/btw242","volume":"33","author":"YA Kim","year":"2017","unstructured":"Kim YA, Madan S, Przytycka TM (2017) Wesme: uncovering mutual exclusivity of cancer drivers and beyond. Bioinformatics 33(6):814\u2013821","journal-title":"Bioinformatics"},{"key":"3535_CR17","doi-asserted-by":"crossref","unstructured":"Kim HW, Park JE, Baek M, Kim H, Ji HW, Yun SH, Jeong D, Ham J, Park S, Lu X, Kang HS, Kim SJ (2022) Matrix metalloproteinase-1 (mmp1) upregulation through promoter hypomethylation enhances tamoxifen resistance in breast cancer. Cancers (Basel) 14 (5)","DOI":"10.3390\/cancers14051232"},{"issue":"6","key":"3535_CR18","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.celrep.2018.01.030","volume":"22","author":"K Kurmi","year":"2018","unstructured":"Kurmi K, Hitosugi S, Wiese EK, Boakye-Agyeman F, Gonsalves WI, Lou Z, Karnitz LM, Goetz MP, Hitosugi T (2018) Carnitine palmitoyltransferase 1A has a lysine succinyltransferase activity. Cell Rep 22(6):1365\u20131373","journal-title":"Cell Rep"},{"issue":"3","key":"3535_CR19","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3892\/ol.2016.4837","volume":"12","author":"KH Lee","year":"2016","unstructured":"Lee KH, Koh M, Moon A (2016) Farnesyl transferase inhibitor FTI-277 inhibits breast cell invasion and migration by blocking H-Ras activation. Oncol Lett 12(3):2222\u20132226","journal-title":"Oncol Lett"},{"issue":"1","key":"3535_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02684-1","volume":"23","author":"M Li","year":"2023","unstructured":"Li M, Wei X, Zhang SS, Li S, Chen SH, Shi SJ, Zhou SH, Sun DQ, Zhao QY, Xu Y (2023) Recognition of refractory Mycoplasma pneumoniae pneumonia among Mycoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model. BMC Pulm Med 23(1):383","journal-title":"BMC Pulm Med"},{"key":"3535_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114505","volume":"154","author":"Y Li","year":"2025","unstructured":"Li Y, Guo T, He J, Liu D, Peng S, Xu A (2025) Slc35a2-mediated bisected GlcNAc-modified extracellular vesicles enhance immune regulation in breast cancer lung metastasis. Int Immunopharmacol 154:114505","journal-title":"Int Immunopharmacol"},{"key":"3535_CR22","doi-asserted-by":"crossref","unstructured":"Limmer A, Engler A, Kattner S, Gregorius J, Pattberg KT, Schulz R, Schwab J, Roth J, Vogl T, Krawczyk A, Witzke O, Zelinskyy G, Dittmer U, Brenner T, Berger MM (2023) Patients with sars-cov-2-induced viral sepsis simultaneously show immune activation, impaired immune function and a procoagulatory disease state. Vaccines (Basel) 11 (2)","DOI":"10.3390\/vaccines11020435"},{"key":"3535_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.682002","volume":"9","author":"TT Liu","year":"2021","unstructured":"Liu TT, Li R, Huo C, Li JP, Yao J, Ji XL, Qu YQ (2021) Identification of CDK2-related immune forecast model and CeRNA in lung adenocarcinoma, a pan-cancer analysis. Front Cell Dev Biol 9:682002","journal-title":"Front Cell Dev Biol"},{"key":"3535_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115713","volume":"168","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang R, Wang Y, Duan Y, Zhan H (2023) Targeting succinylation-mediated metabolic reprogramming as a potential approach for cancer therapy. Biomed Pharmacother 168:115713","journal-title":"Biomed Pharmacother"},{"key":"3535_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.622198","volume":"9","author":"W Lu","year":"2021","unstructured":"Lu W, Che X, Qu X, Zheng C, Yang X, Bao B, Li Z, Wang D, Jin Y, Wang Y, Xiao J, Qi J, Liu Y (2021) Succinylation regulators promote clear cell renal cell carcinoma by immune regulation and RNA N6-methyladenosine methylation. Front Cell Dev Biol 9:622198","journal-title":"Front Cell Dev Biol"},{"key":"3535_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.866014","volume":"12","author":"SG Manore","year":"2022","unstructured":"Manore SG, Doheny DL, Wong GL, Lo HW (2022) IL-6\/JAK\/STAT3 signaling in breast cancer metastasis: Biology and treatment. Front Oncol 12:866014","journal-title":"Front Oncol"},{"issue":"11","key":"3535_CR27","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP (2018) MAFtools: Efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28(11):1747\u20131756","journal-title":"Genome Res"},{"issue":"10","key":"3535_CR28","first-page":"4683","volume":"11","author":"R Mu","year":"2021","unstructured":"Mu R, Ma Z, Lu C, Wang H, Cheng X, Tuo B, Fan Y, Liu X, Li T (2021) Role of succinylation modification in thyroid cancer and breast cancer. Am J Cancer Res 11(10):4683\u20134699","journal-title":"Am J Cancer Res"},{"issue":"9","key":"3535_CR29","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/j.1349-7006.2002.tb02479.x","volume":"93","author":"JS Nam","year":"2002","unstructured":"Nam JS, Ino Y, Sakamoto M, Hirohashi S (2002) RAS farnesylation inhibitor FTI-277 restores the E-cadherin\/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. Jpn J Cancer Res 93(9):1020\u20131028","journal-title":"Jpn J Cancer Res"},{"key":"3535_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101097","volume":"86","author":"S Pan","year":"2022","unstructured":"Pan S, Chen R (2022) Pathological implication of protein post-translational modifications in cancer. Mol Aspects Med 86:101097","journal-title":"Mol Aspects Med"},{"issue":"1","key":"3535_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gendis.2018.02.003","volume":"5","author":"Y Qin","year":"2018","unstructured":"Qin Y, Feng H, Chen M, Wu H, Zheng X (2018) Infiniumpurify: An R package for estimating and accounting for tumor purity in cancer methylation research. Genes Dis 5(1):43\u201345","journal-title":"Genes Dis"},{"issue":"6","key":"3535_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","volume":"377","author":"M Robson","year":"2017","unstructured":"Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, Delaloge S, Li W, Tung N, Armstrong A, Wu W, Goessl C, Runswick S, Conte P (2017) Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med 377(6):523\u2013533","journal-title":"N Engl J Med"},{"issue":"8","key":"3535_CR33","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/jnci\/djae074","volume":"116","author":"RL Sandoval","year":"2024","unstructured":"Sandoval RL, Bottosso M, Tianyu L, Polidorio N, Bychkovsky BL, Verret B, Gennari A, Cahill S, Achatz MI, Caron O, Imbert-Bouteille M, Nogues C, Mawell KN, Fortuno C, Spurdle AB, Tayob N, Andre F, Garber JE (2024) TP53-associated early breast cancer: new observations from a large cohort. J Natl Cancer Inst 116(8):1246\u20131254","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"3535_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2024.110834","volume":"116","author":"B Sarker","year":"2024","unstructured":"Sarker B, Rahaman MM, Alamin MH, Islam AM, Mollah NHM (2024) Boosting edgeR (robust) by dealing with missing observations and gene-specific outliers in RNA-seq profiles and its application to explore biomarker genes for diagnosis and therapies of ovarian cancer. Genomics 116(3):110834","journal-title":"Genomics"},{"key":"3535_CR35","doi-asserted-by":"crossref","unstructured":"Seager RJ, Hajal C, Spill F, Kamm RD, Zaman MH (2017) Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression. Converg Sci Phys Oncol 3","DOI":"10.1088\/2057-1739\/aa7e86"},{"issue":"2","key":"3535_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.trecan.2020.01.007","volume":"6","author":"A Shahbandi","year":"2020","unstructured":"Shahbandi A, Nguyen HD, Jackson JG (2020) TP53 mutations and outcomes in breast cancer: reading beyond the headlines. Trends Cancer 6(2):98\u2013110","journal-title":"Trends Cancer"},{"key":"3535_CR37","doi-asserted-by":"crossref","unstructured":"Shihab I, Khalil BA, Elemam NM, Hachim IY, Hachim MY, Hamoudi RA, Maghazachi AA (2020) Understanding the role of innate immune cells and identifying genes in breast cancer microenvironment. Cancers (Basel) 12 (8)","DOI":"10.3390\/cancers12082226"},{"key":"3535_CR38","doi-asserted-by":"crossref","unstructured":"Trofimova O, Korotkaja K, Skrastina D, Jansons J, Spunde K, Isaguliants M, Zajakina A (2021) Alphavirus-driven interferon gamma (ifng) expression inhibits tumor growth in orthotopic 4t1 breast cancer model. Vaccines (Basel) 9 (11)","DOI":"10.3390\/vaccines9111247"},{"issue":"4","key":"3535_CR39","first-page":"308","volume":"75","author":"NS Wagle","year":"2025","unstructured":"Wagle NS, Nogueira L, Devasia TP, Mariotto AB, Yabroff KR, Islami F, Jemal A, Alteri R, Ganz PA, Siegel RL (2025) Cancer treatment and survivorship statistics, 2025. CA Cancer J Clin 75(4):308\u2013340","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3535_CR40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP (2019) Breast cancer treatment: a review. JAMA 321(3):288\u2013300","journal-title":"JAMA"},{"issue":"1","key":"3535_CR41","first-page":"145","volume":"16","author":"P Wang","year":"2018","unstructured":"Wang P, Wang F, Wang L, Pan J (2018) Proprotein convertase subtilisin\/kexin type 6 activates the extracellular signal-regulated kinase 1\/2 and wnt family member 3a pathways and promotes in vitro proliferation, migration and invasion of breast cancer mda-mb-231 cells. Oncol Lett 16(1):145\u2013150","journal-title":"Oncol Lett"},{"issue":"1","key":"3535_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/jcmm.13920","volume":"23","author":"C Wang","year":"2019","unstructured":"Wang C, Zhang C, Li X, Shen J, Xu Y, Shi H, Mu X, Pan J, Zhao T, Li M, Geng B, Xu C, Wen H, You Q (2019) Cpt1a-mediated succinylation of s100a10 increases human gastric cancer invasion. J Cell Mol Med 23(1):293\u2013305","journal-title":"J Cell Mol Med"},{"issue":"3","key":"3535_CR43","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.molonc.2010.04.004","volume":"4","author":"B Weigelt","year":"2010","unstructured":"Weigelt B, Geyer FC, Reis-Filho JS (2010) Histological types of breast cancer: how special are they? Mol Oncol 4(3):192\u2013208","journal-title":"Mol Oncol"},{"issue":"7","key":"3535_CR44","first-page":"3405","volume":"12","author":"SY Xie","year":"2022","unstructured":"Xie SY, Shi DB, Ouyang Y, Lin F, Chen XY, Jiang TC, Xia W, Guo L, Lin HX (2022) Shmt2 promotes tumor growth through vegf and mapk signaling pathway in breast cancer. Am J Cancer Res 12(7):3405\u20133421","journal-title":"Am J Cancer Res"},{"issue":"1","key":"3535_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP, Huang L, Liu CC, Shao ZM, Yu KD (2025) Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther 10(1):49","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"3535_CR46","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2907240","volume":"29","author":"J Yan","year":"2024","unstructured":"Yan J, Wu L, Zheng M, Pan F (2024) Exploring programmed cell death-related biomarkers and disease therapy strategy in nasopharyngeal carcinoma using transcriptomics. Front Biosci (Landmark Ed) 29(7):240","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"10","key":"3535_CR47","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1007\/s11064-019-02780-x","volume":"44","author":"Y Yang","year":"2019","unstructured":"Yang Y, Gibson GE (2019) Succinylation links metabolism to protein functions. Neurochem Res 44(10):2346\u20132359","journal-title":"Neurochem Res"},{"issue":"4","key":"3535_CR48","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/jhered\/esac006","volume":"113","author":"L Yang","year":"2022","unstructured":"Yang L, Qu Q, Hao Z, Sha K, Li Z, Li S (2022) Powerful identification of large quantitative trait loci using genome-wide r\/glmnet-based regression. J Hered 113(4):472\u2013478","journal-title":"J Hered"},{"issue":"3","key":"3535_CR49","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10549-017-4149-0","volume":"162","author":"SK Yeo","year":"2017","unstructured":"Yeo SK, French R, Spada F, Clarkson R (2017) Opposing roles of nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells. Breast Cancer Res Treat 162(3):465\u2013477","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3535_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-00965-y","volume":"8","author":"Y Yu","year":"2022","unstructured":"Yu Y, Fang L (2022) Circrpap2 regulates the alternative splicing of ptk2 by binding to srsf1 in breast cancer. Cell Death Discov 8(1):152","journal-title":"Cell Death Discov"},{"issue":"7","key":"3535_CR51","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1158\/2326-6066.CIR-18-0658","volume":"7","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhang Z (2019) Recharacterizing tumor-infiltrating lymphocytes by single-cell RNA sequencing. Cancer Immunol Res 7(7):1040\u20131046","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"3535_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1055\/a-2548-1568","volume":"57","author":"H Zhang","year":"2025","unstructured":"Zhang H, Fan MD, Hu Y, Yang Q, Jiang JW, Xu M (2025) Prognostic assessment and analysis of underlying biological mechanisms of prostate cancer based on estrogen-related genes. Horm Metab Res 57(4):273\u2013285","journal-title":"Horm Metab Res"},{"key":"3535_CR53","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Tian Q, Gao H, Zhu L, Yang J, Zhang J, Yang J (2022) Correlation between immune-related genes and tumor-infiltrating immune cells with the efficacy of neoadjuvant chemotherapy for breast cancer. Front Genet 13:90561","journal-title":"Front Genet"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00726-026-03535-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-026-03535-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-026-03535-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:02:47Z","timestamp":1791921767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00726-026-03535-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3535"],"URL":"https:\/\/doi.org\/10.1007\/s00726-026-03535-z","relation":{},"ISSN":["1438-2199"],"issn-type":[{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval and consent were not required as this study was based on publicly available data.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"59"}}